Common
- Symbol
- FENC
- Exchange
- NASDAQ
- Classification
- OTHER
- Status
- Current
Current Report · Items 5.07 · 8-K
Fennec Pharmaceuticals Inc.
Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 10, 2026, Fennec Pharmaceuticals Inc. (the “Company”) held an annual meeting of shareholders (the “Meeting”). The shareholders approved all proposals considered at the Meeting and approved all nominees of the Company for director, as follows: 1.…
Company context
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Fennec is focused on the commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in cancer patients. PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and United Kingdom (U.K.) approval in October 2023 under the brand name PEDMARQSIÒ.
Current securities
Registered securities in this filing
FENNEC PHARMACEUTICALS INC. · 8-K · Filed 2026-06-10
Disclosure sections
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 10, 2026, Fennec Pharmaceuticals
Inc. (the “Company”) held an annual meeting of shareholders (the “Meeting”). The shareholders approved all proposals
considered at the Meeting and approved all nominees of the Company for director, as follows:
1. The following five (5) nominees were elected to serve as directors, each to serve until the next annual meeting of shareholders
of the Company or until their respective successor shall have been duly elected or duly approved:
Name of Nominee Votes For Votes Withheld Broker Non-Votes
──────────────────────────────────────────────────────────────────────────────
Dr. Khalid Islam 20,246,596 126,891 5,881,885
Chris A. Rallis 20,126,058 247,429 5,881,885
Marco Brughera 20,237,230 136,257 5,881,885
Jodi Cook 20,191,538 181,949 5,881,885
Jeffrey Hackman 20,282,707 90,780 5,881,885
2. The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board
of Directors to fix their remuneration was approved based on the following vote:
Votes For 26,091,716
Votes Withheld 134,491
Votes Against 29,165
Broker Non-Votes 0
3. The resolution to vote on the advisory vote on executive compensation was approved based on the following vote:
Votes For 19,326,750
Votes Against 336,060
Abstentions 710,677
Broker Non-Votes 5,881,885
4. The resolution to vote on the advisory vote on the frequency of advisory votes on compensation of Corporations named executive
officers was approved based on the following vote:
Votes For Evey One Year 18,235,648
Votes For Evey Two Years 2,326
Votes For Evey Three Years 2,086219
Abstentions 49,294
5. The resolution to approve certain amendments to Corporation’s 2020 Equity Incentive Plan was approved based on the following
vote:
Votes For(1) 17,425,439
Votes Against 1,429,951
Abstentions 751,944
Broker Non-Votes 5,881,885
(1)
An aggregate of 766,153 common shares, representing the aggregate number of shares held by officers and directors of the Corporation,
has been deducted from the FOR vote in respect of this resolution.
6. The
resolution to ratify and approve the adoption of Fennec’s 2026 Equity Inducement Plan was approved based on the following vote:.
Votes For 18,626,207
Votes Against 1,033,779
Abstentions 713,501
Broker Non-Votes 5,881,885